Putative adverse outcome pathways relevant to neurotoxicity

References

• Adeleye Y, Andersen M, Clewell R, Davies M, Dent M, Edwards S, et al. (2014). Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment. Toxicology. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Aldridge WN. (1996). Mechanisms and concepts in toxicology. W. N. Aldridge, University of Surrey, UK. Taylor & Francis. 1996.
   Google Scholar
• Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, et al. (2010). Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem, 29, 730–41.
   PubMed Web of Science ®Google Scholar
• Bal-Price AK, Coecke S, Costa L, Crofton KM, Fritsche E, Goldberg A, et al. (2012). Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX, 29, 202–15.
   PubMedGoogle Scholar
• Bal-Price AK, Hogberg HT, Buzanska L, Lenas P, van Vliet E, Hartung T. (2010). In vitro developmental neurotoxicity (DNT) testing: Relevant models and endpoints. Neurotoxicology, 31, 545–54.
   PubMed Web of Science ®Google Scholar
• Barone S Jr, Das KP, Lassiter TL, White LD. (2000). Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology, 21, 15–36.
   PubMed Web of Science ®Google Scholar
• Barone S Jr, Stanton ME, Mundy WR. (1995). Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging. Neurobiol Aging 16, 723–35.
   PubMed Web of Science ®Google Scholar
• Bishop NA, Lu T, Yankner BA. (2010). Neural mechanisms of ageing and cognitive decline. Nature, 464, 529–35.
   PubMed Web of Science ®Google Scholar
• Bloom B, Cohen RA, Freeman G. (2010). Summary health statistics for U.S. children: National Health Interview Survey, 2009. Vital Health Stat, 247, 1–82.
   Google Scholar
• Burbacher TM, Rodier PM, Weiss B. (1990). Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol, 12, 191–202.
   PubMed Web of Science ®Google Scholar
• Bushnell PJ, Kavlock RJ, Crofton KM, Weiss B, Rice DC. (2010). Behavioural toxicology in 21st century: challenges and opportunities for behavioural scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009. Neurotox Teratol, 32, 313–28.
   Google Scholar
• Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, et al. (2007). Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect, 115, 924–31.
   PubMed Web of Science ®Google Scholar
• Collins FS, Gray GM, Bucher JR. (2008). Toxicology. Transforming environmental health protection. Science, 319, 906–7.
   PubMed Web of Science ®Google Scholar
• Crofton KM, Mundy WR, Lein PJ, Bal-Price A, Coecke S, Seiler AE, et al. (2011). Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX, 28, 9–15.
   PubMedGoogle Scholar
• Crofton KM, Zoeller RT. (2005). Mode of action: neurotoxicity induced by thyroid hormone disruption during development--hearing loss resulting from exposure to PHAHs. Crit Rev Toxicol, 35, 759–769.
   Web of Science ®Google Scholar
• Ganguly K, Schinder AF, Wong ST, Poo M. (2001). GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell, 105, 521–32.
   PubMed Web of Science ®Google Scholar
• Gassmann K, Abel J, Bothe H, Haarmann-Stemmann T, Merk HF, Quasthoff KN, et al. (2010). Species-specific differential AhR-expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environ Health Perspect, 118, 1571–7.
   PubMed Web of Science ®Google Scholar
• Gemma C, Vila J, Bachstetter A, Bickford PC. (2007). Oxidative stress and the aging brain: From theory to prevention. In: Riddle DR, Ed. Brain Aging: Models, Methods, and Mechanisms. Boca Raton (FL): CRC Press, Chapter 15.
   Google Scholar
• Giedd JN. (2008). The teen brain: insights from neuroimaging. J Adolesc Health, 42, 335–43.
   PubMed Web of Science ®Google Scholar
• Giedd JN. (2004). Structural magnetic resonance imaging of the adolescent brain. Ann N Y Acad Sci, 1021, 77–85.
   PubMed Web of Science ®Google Scholar
• Graham DG, Amarnath V, Valentine WM, Pyle SJ, Anthony DC. (1995). Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol, 25, 91–112.
   PubMed Web of Science ®Google Scholar
• Guerri C, Pascual M. (2010). Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence. Alcohol, 44, 15–26.
   PubMed Web of Science ®Google Scholar
• Harrill JA, Freudenrich TM, Robinette BL, Mundy WR. (2011). Comparative sensitivity of human and rat neural cultures to chemical-induced inhibition of neurite outgrowth. Toxicol Appl Pharmacol, 256, 268–80.
   PubMed Web of Science ®Google Scholar
• Hsieh HL, Yang CM. (2013). Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res Int, 2013, 484613.
   PubMed Web of Science ®Google Scholar
• IPCS. (2007). IPCS Mode of Action Framework. Harmonization project document No4. World Health Organisation. Geneva, Switzerland.
   Google Scholar
• Jenner P, Marsden CD. (1986). The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. J Neural Transm Suppl, 20, 11–39.
   PubMedGoogle Scholar
• Jevtovic-Todorovic V, Absalom AR, Blomgren K, Brambrink A, Crosby G, Culley DJ, et al. (2013). Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth, 111, 143–51.
   PubMed Web of Science ®Google Scholar
• Johnson T, Monk T, Rasmussen LS, Abildstrom H, Houx P, Korttila K, et al.; ISPOCD2 Investigators. (2002). Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology, 96, 1351–7.
   PubMed Web of Science ®Google Scholar
• Kleinstreuer N, Dix D, Rountree M, Baker N, Sipes N, et al. (2013). A computational model predicting disruption of blood vessel development. PLoS Comput Biol, 9, e1002996.
   Web of Science ®Google Scholar
• Landrigan PJ, Lambertini L, Birnbaum LS. (2012). A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities. Environ Health Perspect, 120, a258–60.
   Web of Science ®Google Scholar
• Landrigan PJ, Rauh VA, Galvez MP. (2010). Environmental justice and the health of children. Mt Sinai J Med, 77, 178–87.
   PubMed Web of Science ®Google Scholar
• Lein P, Locke P, Goldberg A. (2007). Meeting report: alternatives for developmental neurotoxicity testing – Test-Smart developmental neurotoxicology. Environ Health Perspect, 115, 764–8.
   PubMed Web of Science ®Google Scholar
• Lein P, Silbergeld E, Locke P, Goldberg AM. (2005). In vitro and other alternative approaches to developmental neurotoxicity testing (DNT). Environ Toxicol Pharmacol, 19, 735–44.
   PubMed Web of Science ®Google Scholar
• LoPachin RM, DeCaprio AP. (2005). Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol Sci, 86, 214–25.
   PubMed Web of Science ®Google Scholar
• McDonald ME, Paul JF. (2010). Timing of increased autistic disorder cumulative incidence. Environ Sci Technol, 44, 2112–8.
   PubMed Web of Science ®Google Scholar
• MacKay C, Davies M, Summerfield V, Maxwell G. (2013). From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment. ALTEX, 30, 473–86.
   PubMedGoogle Scholar
• Meek ME, Klaunig JE. (2010). Proposed mode of action of benzene induced leukemia: interpreting available data and identifying critical data gaps for risk assessment. Chem Biol Interact, 184, 279–85.
   PubMed Web of Science ®Google Scholar
• Meek ME, Boobis A, Cote I, Dellarco V, Fotakis G, Munn S, et al. (2014a). New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol, 34, 1–18.
   PubMed Web of Science ®Google Scholar
• Meek ME, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R. (2014). Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol, 34, 595–606.
   PubMed Web of Science ®Google Scholar
• Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al. (1998). Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 351, 857–61.
   Google Scholar
• Mombelli E. (2012). Evaluation of the OECD (Q)SAR Application Toolbox for the profiling of estrogen receptor binding affinities. SAR QSAR Environ Res, 23, 37–57.
   PubMed Web of Science ®Google Scholar
• NRC. (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC: The National Academies Press.
   Google Scholar
• OECD. (2013). Guidance document on developing and assessing adverse outcome pathways. Series on Testing and Assessment No. 184 ENV/JM/MONO(2013)6. Available at: http://search.oecd.org/officialdocuments/displaydocumentpdf/?cote = env/jm/mono(2013)6anddoclanguage = en Accessed on 29 November 2013.
   Google Scholar
• Patlewicz GY, Lander DR. (2013). A step change towards risk assessment in the 21st century. Front Biosci (Elite Ed), 5, 418–34.
   PubMedGoogle Scholar
• Paus T, Collins DL, Evans AC, Leonard G, Pike B, Zijdenbos A. (2001). Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull, 54, 255–66.
   PubMed Web of Science ®Google Scholar
• Perluigi M, Swomley AM, Butterfield DA. (2014). Redox proteomics and the dynamic molecular landscape of the aging brain. Ageing Res Rev, 13, 75–89.
   PubMed Web of Science ®Google Scholar
• Rao DB, Jortner BS, Sills RC. (2014). Animal models of peripheral neuropathy due to environmental toxicants. ILAR J, 54, 315–23.
   PubMed Web of Science ®Google Scholar
• Rice D, Barone S Jr. (2000). Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect, 108, 511–33.
   PubMed Web of Science ®Google Scholar
• Rohan D, Buggy DJ, Crowley S, Ling FK, Gallagher H, Regan C, Moriarty DC. (2005). Increased incidence of post- operative cognitive dysfunction 24 hr after minor surgery in the elderly. Can J Anaesth, 52, 137–142.
   PubMed Web of Science ®Google Scholar
• Sanders T, Liu Y, Buchner V, Tchounwou PB. (2009). Neurotoxic effects and biomarkers of lead exposure. Rev Environ Health, 24, 15–45.
   PubMedGoogle Scholar
• Schmieder PK, Ankley G, Mekenyan O, Walker JD, Bradbury S. (2003). Quantitative structure-activity relationship models for prediction of estrogen receptor binding affinity of structurally diverse chemicals. Environ Toxicol Chem, 22, 1844–54.
   PubMed Web of Science ®Google Scholar
• Schmieder PK, Tapper MA, Denny JS, Kolanczyk RC, Sheedy BR, Henry TR, Veith GD. (2004). Use of trout liver slices to enhance mechanistic interpretation of estrogen receptor binding for cost-effective prioritization of chemicals within large inventories. Environ Sci Technol, 38, 6333–42.
   PubMed Web of Science ®Google Scholar
• Shafer TJ, Meyer DA, Crofton KM. (2005). Developmental neurotoxicity of pyrethroid insecticides: critical review and future research needs. Environ Health Perspect, 113, 123–36.
   PubMed Web of Science ®Google Scholar
• Stiles J, Jernigan TL. (2010). The basics of brain development. Neuropsychol Rev, 20, 327–48.
   PubMed Web of Science ®Google Scholar
• Swartzwelder HS, Wilson WA, Tayyeb MI. (1995a). Age-dependent inhibition of long-term potentiation by ethanol in immature versus mature hippocampus. Alcohol Clin Exp Res, 19, 1480–5.
   PubMed Web of Science ®Google Scholar
• Swartzwelder HS, Wilson WA, Tayyeb MI. (1995b). Differential sensitivity of NMDA receptor-mediated synaptic potentials to ethanol in immature versus mature hippocampus. Alcohol Clin Exp Res, 19, 320–3.
   PubMed Web of Science ®Google Scholar
• Thomas RS, Philbert MA, Auerbach SS, Wetmore BA, Devito MJ, Cote I, et al. (2013). Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol Sci, 136:4–18.
   PubMed Web of Science ®Google Scholar
• Tipton KF, Singer TP. (1993). Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem, 61:1191–206.
   PubMed Web of Science ®Google Scholar
• van Wijngaarden P, Franklin RJ. (2013). Ageing stem and progenitor cells: implications for rejuvenation of the central nervous system. Development, 140, 2562–75
   PubMed Web of Science ®Google Scholar
• Villeneuve D, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone C A, et al. (2014a). Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci. (in press; DOI: 10.1093/toxsci/kfu199).
   Web of Science ®Google Scholar
• Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, et al. (2014b). Adverse outcome pathway (AOP) development II: best practices. Toxicol Sci. (in press; DOI: 10.1093/toxsci/kfu200).
   Web of Science ®Google Scholar
• Vinken M. (2013). The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology, 312, 158–65.
   PubMed Web of Science ®Google Scholar
• Walhovd KB, Fjell AM, Espeseth T. (2014). Cognitive decline and brain pathology in aging - need for a dimensional, lifespan and systems vulnerability view. Scand J Psychol [Epub ahead of print].
   Web of Science ®Google Scholar
• Watanabe KH, Andersen ME, Basu N, Carvan MJ III, Crofton KM, King KA, et al. (2011). Defining and modeling known adverse outcome pathways: Domoic acid and neuronal signaling as a case study. Environ Toxicol Chem, 30, 9–21.
   PubMed Web of Science ®Google Scholar
• Westerholz S, de Lima AD, Voigt T. (2010). Regulation of early spontaneous network activity and GABAergic neurons development by thyroid hormone. Neuroscience, 168, 573–89.
   PubMed Web of Science ®Google Scholar
• Woodruff TJ, Zeise L, Axelrad DA, Guyton KZ, Janssen S, Miller M, et al. (2008). Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making. Environ Health Perspect, 116, 1568–75.
   PubMed Web of Science ®Google Scholar